These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1831839)

  • 1. Technetium-99m-MAG3 clearance as a parameter of effective renal plasma flow in patients with proteinuria and lowered serum albumin levels.
    Kengen RA; Meijer S; Beekhuis H; Piers DA
    J Nucl Med; 1991 Sep; 32(9):1709-12. PubMed ID: 1831839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
    Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
    J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of renal scintigraphy and clearance with 99mTc-MAG3 and 123I-hippurate in patients with renal disorders.
    Müller-Suur R; Bois-Svensson I; Mesko L
    Contrib Nephrol; 1990; 79():32-5. PubMed ID: 2146087
    [No Abstract]   [Full Text] [Related]  

  • 4. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
    Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
    Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 99mTc-MAG3: dynamic studies in patients with renal disease.
    Schaap GH; Alferink TH; de Jong RB; Oe PL; Roos JC; Donker AJ
    Eur J Nucl Med; 1988; 14(1):28-31. PubMed ID: 2968259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective validation of a single sample technique to determine technetium-99m-MAG3 clearance.
    Taylor A; Corrigan P; Eshima D; Folks R
    J Nucl Med; 1992 Sep; 33(9):1620-2. PubMed ID: 1387682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
    Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
    J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
    Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
    Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of technetium-99m-MAG3 in humans.
    Bubeck B; Brandau W; Weber E; Kälble T; Parekh N; Georgi P
    J Nucl Med; 1990 Aug; 31(8):1285-93. PubMed ID: 2143528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of renal scintigraphy and clearance with technetium-99m-MAG3 and iodine-123-hippurate in patients with renal disorders.
    Müller-Suur R; Bois-Svensson I; Mesko L
    J Nucl Med; 1990 Nov; 31(11):1811-7. PubMed ID: 2146371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technetium-99m MAG3, a comparison with iodine-123 and iodine-131 orthoiodohippurate, in patients with renal disorders.
    Jafri RA; Britton KE; Nimmon CC; Solanki K; Al-Nahhas A; Bomanji J; Fettich J; Hawkins LA
    J Nucl Med; 1988 Feb; 29(2):147-58. PubMed ID: 2964516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of technetium 99m mercaptoacetyltriglycine plasma clearance by use of one single plasma sample.
    Müller-Suur R; Magnusson G; Bois-Svensson I; Jansson B
    Eur J Nucl Med; 1991; 18(1):28-31. PubMed ID: 1826882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The estimation of effective renal plasma flow (ERPF) based on two compartment analysis using 99mTc-mercaptoacetyltriglycine (99mTc-MAG3)].
    Ha-Kawa SK; Suga Y; Satou H; Tanaka Y
    Kaku Igaku; 1994 Feb; 31(2):175-81. PubMed ID: 8121073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
    Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
    Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of renal transplant survival from early postoperative radioisotope studies.
    Russell CD; Yang H; Gaston RS; Hudson SL; Diethelm AG; Dubovsky EV
    J Nucl Med; 2000 Aug; 41(8):1332-6. PubMed ID: 10945523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of altered physiologic states on clearance and biodistribution of technetium-99m MAG3, iodine-131 OIH, and iodine-125 iothalamate.
    Taylor A; Eshima D
    J Nucl Med; 1988 May; 29(5):669-75. PubMed ID: 2967354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results comparing OIH, 99mTc-MAG3 and iothalamate in a rat model of renal ischemia.
    Eshima D; Greene J; Taylor A
    Contrib Nephrol; 1990; 79():24-7. PubMed ID: 2146085
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary results comparing the extraction efficiencies of 131I-OIH and 99mTc-MAG3 in rat models of ischemia, renal artery stenosis, and ciclosporin toxicity.
    Taylor A; Greene J; Eshima D; Dillehay D
    Contrib Nephrol; 1990; 79():21-3. PubMed ID: 2146084
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of iodine-131 OIH and technetium-99m MAG3 renal imaging in volunteers.
    Taylor A; Eshima D; Fritzberg AR; Christian PE; Kasina S
    J Nucl Med; 1986 Jun; 27(6):795-803. PubMed ID: 2940350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.